KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Other Non Operating Income (2016 - 2025)

Cme (CME) has disclosed Other Non Operating Income for 15 consecutive years, with -$1.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Non Operating Income fell 50.73% to -$1.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.8 billion, a 32.1% decrease, with the full-year FY2025 number at -$4.8 billion, down 32.1% from a year prior.
  • Other Non Operating Income was -$1.3 billion for Q4 2025 at Cme, up from -$1.4 billion in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $311.8 million in Q3 2021 to a low of -$1.4 billion in Q2 2023.
  • A 5-year average of -$735.4 million and a median of -$928.4 million in 2024 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: surged 2265.28% in 2021, then crashed 2368.52% in 2023.
  • Cme's Other Non Operating Income stood at $74.2 million in 2021, then plummeted by 1471.02% to -$1.0 billion in 2022, then grew by 5.51% to -$961.2 million in 2023, then grew by 12.87% to -$837.5 million in 2024, then plummeted by 50.73% to -$1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for CME's Other Non Operating Income are -$1.3 billion (Q4 2025), -$1.4 billion (Q3 2025), and -$1.4 billion (Q2 2025).